Clinical Trials Browser

Anxiety Disorders, Depression, Neoplasms

NCT06665568 2025-05-01

Keta-Care

Phase EARLY_PHASE1 Not yet recruiting

100 enrolled

Caregiver Burden, Anxiety Disorders, Depression, Sleep Initiation and Maintenance Disorders

NCT06001372 2025-04-16

TREK

Phase EARLY_PHASE1 Terminated

2 enrolled 9 charts

Gastrointestinal

Anxiety Disorders, Depression, Gastrointestinal Neoplasms

NCT02415387 2024-07-24

IMPACT

Phase EARLY_PHASE1 Completed

172 enrolled 14 charts

Breast

Breast Neoplasms, Depression

NCT00737399 2024-04-16

Anxiety and Depression Levels in Cancer Patients After Self-Application of EFT (Emotional Freedom Techniques)

Phase EARLY_PHASE1 Active not recruiting

14 enrolled

Gastrointestinal

Anxiety Disorders, Depression, Sleep Initiation and Maintenance Disorders, Neoplasms, Pain, Cholangiocarcinoma

NCT05344625 2024-01-24

KAPTIVATED

Phase EARLY_PHASE1 Withdrawn

Anxiety Disorders, Depression

NCT00957359 2020-10-20

Psilocybin Cancer Anxiety Study

Phase EARLY_PHASE1 Completed

29 enrolled 59 charts

Anxiety Disorders, Depression, Neoplasms

NCT02442739 2018-11-06

Ketamine for Preventing Depression in Patients Undergoing Treatment for Pancreatic or Head and Neck Cancers

Phase EARLY_PHASE1 Withdrawn

GastrointestinalHead & Neck

Depression, Head and Neck Neoplasms, Pancreatic Neoplasms

NCT02836288 2018-11-06

Study of Oral Ketamine Versus Placebo for Treating Depression in Patients Undergoing Treatment for Cancer

Phase EARLY_PHASE1 Completed

4 enrolled

Depression, Neoplasms

Clinical Trials

Effect of Kava on Anxiety and Stress in Cancer Survivors

Keta-Care

TREK

IMPACT

Anxiety and Depression Levels in Cancer Patients After Self-Application of EFT (Emotional Freedom Techniques)

KAPTIVATED

Psilocybin Cancer Anxiety Study

Ketamine for Preventing Depression in Patients Undergoing Treatment for Pancreatic or Head and Neck Cancers

Study of Oral Ketamine Versus Placebo for Treating Depression in Patients Undergoing Treatment for Cancer